Procaps Group S.A. (NASDAQ:PROC) Short Interest Up 455.1% in November

Procaps Group S.A. (NASDAQ:PROC) was the target of a significant increase in short interest during the month of November. As of November 15th, there was short interest totalling 113,800 shares, an increase of 455.1% from the October 31st total of 20,500 shares. Approximately 0.6% of the shares of the company are short sold. Based on an average daily volume of 68,700 shares, the short-interest ratio is currently 1.7 days.

Procaps Group Stock Performance

NASDAQ:PROC traded up $0.73 during trading hours on Wednesday, reaching $2.09. The stock had a trading volume of 205,302 shares, compared to its average volume of 30,771. The stock has a 50 day simple moving average of $1.71 and a 200 day simple moving average of $2.14. Procaps Group has a 12-month low of $0.50 and a 12-month high of $4.95.

About Procaps Group

Procaps Group SA develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory.